Drug · DIN 02498049
IBSRELA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 10, 2026; first marketed November 23, 2020.
- Drug Identification Number (DIN)
- 02498049
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tenapanor A06AX08
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TENAPANOR (TENAPANOR HYDROCHLORIDE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 15, 2020: NOC 23453New Drug Submission (NDS)